Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting...
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with...
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various...
Compete with the best at Fusion Worldwide! Fusion is one of the leading Independent Distributors of Electronic Components and after more than 20 years in business, has grown into a $3B global organization. Life at Fusion is fast-paced, challenging,...
Territory: Boston North, MA - Neurology ...
Hours: Per-Diem. 48 hour monthly requirement at minimum. Every Saturday is required from 7:00 AM to 1:00 PM at Lowell General Main Campus - Patient Service Center. 1 winter &...
The Company Acceleron Fusion is developing a breakthrough new technology to produce clean energy, based on research funded by the US Department of Energy. We are based in Cambridge, MA. We are a small start-up,...
Territory: Boston North, MA - Neurology Target area for territory is Boston - will consider candidates who live within 40 miles of territory boundaries with access to a major airport. Territory boundaries include: Boston, Brookline,...
Jubilant Radiopharma, the fastest growing radiopharmaceutical company in the nation, is seeking a Pharmacy TECHNICIAN II FULL-TIME for its Boston, MA location. Address: 655 Shawmut Rd Canton, MA...
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda'sPrivacy Noticeand Terms of Use. I further...